scispace - formally typeset
Journal ArticleDOI

Therapeutic potential of resveratrol: the in vivo evidence.

Joseph A. Baur, +1 more
- 01 Jun 2006 - 
- Vol. 5, Iss: 6, pp 493-506
Reads0
Chats0
TLDR
A comprehensive and critical review of the in vivo data on resveratrol is provided, and its potential as a therapeutic for humans is considered.
Abstract
Resveratrol, a constituent of red wine, has long been suspected to have cardioprotective effects. Interest in this compound has been renewed in recent years, first from its identification as a chemopreventive agent for skin cancer, and subsequently from reports that it activates sirtuin deacetylases and extends the lifespans of lower organisms. Despite scepticism concerning its bioavailability, a growing body of in vivo evidence indicates that resveratrol has protective effects in rodent models of stress and disease. Here, we provide a comprehensive and critical review of the in vivo data on resveratrol, and consider its potential as a therapeutic for humans.

read more

Citations
More filters
Journal ArticleDOI

Resveratrol reduces vascular cell senescence through attenuation of oxidative stress by SIRT1/NADPH oxidase-dependent mechanisms.

TL;DR: It is suggested that Res was able to reverse the senescence process in aorta induced by HFS in rats or induced by the exposure to high glucose in cultured BAECs, suggesting the underlying mechanism is at least SIRT1/NADPH oxidase pathway dependent.
Journal ArticleDOI

Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats

TL;DR: Age‐associated changes in tryptophan metabolism have the potential to impact upon major biological processes, including lymphocyte function, pyridine (NAD(P)(H)) synthesis and N‐methyl‐d‐aspartate (NMDA)‐mediated synaptic transmission, and may therefore contribute to several degenerative changes of the elderly.
Journal ArticleDOI

Resveratrol in cancer management: where are we and where we go from here?

TL;DR: In this direction, some possible scenarios include enhancing the bioavailability of resveratrol by novel mechanism-based combinations with agents that can inhibit the in vivo metabolism of reserveratrol as mentioned in this paper.
Journal ArticleDOI

An anti-inflammatory cell-free collagen/resveratrol scaffold for repairing osteochondral defects in rabbits.

TL;DR: The anti-inflammatory acellular Coll/Res scaffolds are convenient to administer in vivo, holding a greater potential for future clinical applications.
Journal ArticleDOI

Resveratrol-loaded calcium-pectinate beads: effects of formulation parameters on drug release and bead characteristics.

TL;DR: Observations from the present study revealed that optimized Ca-pectinate beads can encapsulate a very high amount of resveratrol and can be used for delayed release and site-specific delivery to the lower GI tract.
References
More filters
Journal ArticleDOI

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

TL;DR: Experiments with guinea-pig lung suggest that some of the therapeutic effects of sodium salicylate and aspirin-like drugs are due to inhibition of the synthesis of prostaglandins.
Journal ArticleDOI

Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes

TL;DR: It is suggested that resveratrol, a common constituent of the human diet, merits investigation as a potential cancer chemopreventive agent in humans.
Journal ArticleDOI

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

TL;DR: The potent activator resveratrol, a polyphenol found in red wine, lowers the Michaelis constant of SIRT1 for both the acetylated substrate and NAD+, and increases cell survival by stimulating Sirt1-dependent deacetylation of p53.
Journal ArticleDOI

Wine, alcohol, platelets, and the French paradox for coronary heart disease

TL;DR: Data from Caerphilly, Wales, show that platelet aggregation, which is related to CHD, is inhibited significantly by alcohol at levels of intake associated with reduced risk of CHD.
Journal ArticleDOI

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

TL;DR: A balance between formation of anti- and pro-aggregatory substances by enzymes could also contribute to the maintenance of the integrity of vascular endothelium and explain the mechanism of formation of intra-arterial thrombi in certain physiopathological conditions.
Related Papers (5)